{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:48:15Z","timestamp":1788202095343,"version":"build-2803163510"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Plaque excision and grafting (PEG) has been recommended for patients with Peyronie\u2019s disease (PD) with &amp;gt;60\u00b0 curvature and\/or hinge effect and strong preoperative erections, while placement of an inflatable penile prosthesis (IPP) is recommended when rigidity is suboptimal. Nevertheless, many patients counseled to undergo an IPP decline and insist on proceeding with PEG due to personal preference or desire to avoid an implant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We aim to review long-term outcomes in patients who underwent PEG for PD at our institution and investigate whether there is any difference in long-term outcomes in patients who undergo PEG despite a recommendation to undergo IPP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective chart review from 2007 to 2021 on PEG surgery performed at a single tertiary care institution in patients \u226518\u00a0years old who had &amp;gt;3\u00a0months of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Postoperative information was gathered from the electronic medical record, including postoperative erectile function, patient satisfaction, and the ability to engage in penetrative sexual intercourse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>An overall 251 patients underwent PEG with a median follow-up of 12 months (IQR, 6-54). Among these, 54 (22%) were initially advised to undergo IPP but elected for PEG. Patients who underwent PEG despite counseling to undergo IPP reported lower postoperative ability to engage in intercourse (51% vs 76%). Seven (13%) patients initially advised to undergo IPP eventually received an IPP, relative to 7 (4%) initially advised to undergo PEG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Thorough preoperative assessment of erectile function and penile deformity can guide clinician counseling and manage patient expectations during decision making between PEG surgery and IPP implantation for PD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>Limitations of this study include its retrospective nature, high attrition to follow-up, and risk of recall and selection bias. This is a large study with a median follow-up of 12\u00a0months, with a high-volume single surgeon who treats patients in a specialized population of complex cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients who were initially counseled to undergo IPP due to suboptimal erectile rigidity but elected for PEG had worse postoperative ability to engage in penetrative intercourse, and a higher proportion of these patients eventually received an IPP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdad164","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:40:05Z","timestamp":1702478405000},"page":"163-168","source":"Crossref","is-referenced-by-count":6,"title":["Long-term outcomes after plaque excision grafting for Peyronie\u2019s disease and subanalysis of patients who undergo the procedure despite preoperative counseling against it"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-1865","authenticated-orcid":false,"given":"William A","family":"Langbo","sequence":"first","affiliation":[{"name":"Department of Urology, Rush University Medical Center , Chicago, IL 60612 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinson","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center , Chicago, IL 60612 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-2288","authenticated-orcid":false,"given":"Petar","family":"Bajic","sequence":"additional","affiliation":[{"name":"Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic , Cleveland, OH 60612 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Urology, Rush University Medical Center , Chicago, IL 60612 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"issue":"6","key":"2024020509070985700_ref1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/iju.14230","article-title":"Peyronie\u2019s disease: contemporary evaluation and management","volume":"27","author":"Ziegelmann","year":"2020","journal-title":"Int J Urol"},{"issue":"3","key":"2024020509070985700_ref2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1464-410X.2006.05969.x","article-title":"Risk factors for Peyronie\u2019s disease: a case-control study","volume":"97","author":"Bjekic","year":"2006","journal-title":"BJU Int"},{"issue":"2","key":"2024020509070985700_ref3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.sxmr.2019.06.004","article-title":"The etiology of Peyronie\u2019s disease: pathogenesis and genetic contributions","volume":"8","author":"Sharma","year":"2020","journal-title":"Sex Med Rev"},{"issue":"3","key":"2024020509070985700_ref4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of Peyronie\u2019s disease: a review","volume":"10","author":"Nelson","year":"2013","journal-title":"J Sex Med"},{"key":"2024020509070985700_ref5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5534\/wjmh.200065","article-title":"The natural history of Peyronie\u2019s disease","volume":"39","author":"Di Maida","year":"2021","journal-title":"World J Mens Health"},{"issue":"5","key":"2024020509070985700_ref6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/18715281113129990055","article-title":"Clinical evaluation of natural history of Peyronie\u2019s disease: our experience, old myths and new certainties","volume":"12","author":"Paulis","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"3","key":"2024020509070985700_ref7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie\u2019s disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"issue":"1","key":"2024020509070985700_ref8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1743-6109.2004.10116.x","article-title":"Peyronie\u2019s disease","volume":"1","author":"Pryor","year":"2004","journal-title":"J Sex Med"},{"issue":"6","key":"2024020509070985700_ref9","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0022-5347(01)68184-9","article-title":"A surgical algorithm for the treatment of Peyronie\u2019s disease","volume":"158","author":"Levine","year":"1997","journal-title":"J Urol"},{"issue":"2","key":"2024020509070985700_ref10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.23736\/S2724-6051.20.03890-4","article-title":"Penile prosthesis implant in the management of Peyronies\u2019 disease","volume":"73","author":"Verze","year":"2021","journal-title":"Minerva Urol Nephrol"},{"issue":"2","key":"2024020509070985700_ref11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.esxm.2019.11.002","article-title":"Prevalence, risk factors, and erectile dysfunction associated with Peyronie\u2019s disease among men seeking urological care","volume":"8","author":"Segundo","year":"2020","journal-title":"Sex Med"},{"issue":"6","key":"2024020509070985700_ref12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41443-022-00600-5","article-title":"Comparison of patient-reported outcomes after penile prosthesis placement in men with and without Peyronie\u2019s disease","volume":"35","author":"Ziegelmann","year":"2022","journal-title":"Int J Impot Res"},{"issue":"6","key":"2024020509070985700_ref13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/j.1743-6109.2007.00600.x","article-title":"Validation of the erection hardness score","volume":"4","author":"Mulhall","year":"2007","journal-title":"J Sex Med"},{"issue":"2","key":"2024020509070985700_ref14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2007.00700.x","article-title":"Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial","volume":"5","author":"McCullough","year":"2008","journal-title":"J Sex Med"},{"issue":"suppl 3","key":"2024020509070985700_ref15","first-page":"11","article-title":"Peyronie\u2019s disease: what do we know and how do we treat it?","volume":"27","author":"Chung","year":"2020","journal-title":"Can J Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/21\/2\/163\/56549845\/qdad164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/21\/2\/163\/56549845\/qdad164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T09:07:52Z","timestamp":1707124072000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/21\/2\/163\/7469892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2024,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdad164","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,12,12]]}}}